ZUCCATO, Cristina
 Distribuzione geografica
Continente #
NA - Nord America 4.797
EU - Europa 2.116
AS - Asia 1.761
SA - Sud America 125
AF - Africa 29
OC - Oceania 18
Totale 8.846
Nazione #
US - Stati Uniti d'America 4.762
CN - Cina 742
SG - Singapore 609
PL - Polonia 567
IT - Italia 427
UA - Ucraina 314
DE - Germania 291
TR - Turchia 182
GB - Regno Unito 150
BR - Brasile 116
SE - Svezia 100
FI - Finlandia 88
ID - Indonesia 70
FR - Francia 53
NL - Olanda 29
CA - Canada 27
IN - India 27
BE - Belgio 19
HK - Hong Kong 18
IR - Iran 18
CZ - Repubblica Ceca 15
PK - Pakistan 15
AU - Australia 14
VN - Vietnam 14
GR - Grecia 12
RU - Federazione Russa 11
AT - Austria 9
MY - Malesia 9
LT - Lituania 8
JP - Giappone 7
KR - Corea 7
AR - Argentina 6
EG - Egitto 6
LY - Libia 6
MX - Messico 6
BD - Bangladesh 5
CH - Svizzera 5
RO - Romania 5
TH - Thailandia 5
TN - Tunisia 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
NZ - Nuova Zelanda 4
PH - Filippine 4
TW - Taiwan 4
EC - Ecuador 3
IL - Israele 3
KZ - Kazakistan 3
MA - Marocco 3
UZ - Uzbekistan 3
ES - Italia 2
IE - Irlanda 2
IQ - Iraq 2
JO - Giordania 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
LI - Liechtenstein 1
MN - Mongolia 1
MT - Malta 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
Totale 8.846
Città #
Woodbridge 573
Warsaw 566
Chandler 411
Fairfield 407
Jacksonville 381
Santa Clara 321
Ashburn 299
Houston 298
Ann Arbor 296
Singapore 281
Beijing 227
Wilmington 181
Seattle 135
Nanjing 134
Ferrara 131
Cambridge 120
Izmir 114
Princeton 91
Bologna 68
Boardman 65
New York 65
Addison 61
Shanghai 60
Jakarta 57
Bremen 55
Milan 51
Redwood City 41
Shenyang 40
San Diego 38
Los Angeles 35
Nanchang 25
Jiaxing 24
Dearborn 22
Jinan 22
Hebei 20
Auburn Hills 19
Changsha 19
Munich 19
Brussels 18
Ferrara di Monte Baldo 17
Hong Kong 17
Tianjin 17
Toronto 16
Falls Church 15
Dong Ket 14
Falkenstein 14
Mountain View 14
Hefei 13
Leiden 13
Brno 12
Guangzhou 12
London 12
Zhengzhou 12
Helsinki 11
Norwalk 11
San Jose 11
Ningbo 9
Varese 9
Verona 9
Fars 8
Frankfurt am Main 8
Indiana 8
Kunming 8
Sydney 8
São Paulo 8
Des Moines 7
Orange 7
Leawood 6
Yogyakarta 6
Cattolica 5
Chengdu 5
Hangzhou 5
Hyderabad 5
Nuremberg 5
Ottawa 5
Rio de Janeiro 5
San Mateo 5
Washington 5
Auckland 4
Benghazi 4
Bournemouth 4
Changchun 4
Fuzhou 4
Kota Bharu 4
Lanzhou 4
Lappeenranta 4
Napoli 4
Philadelphia 4
Piscataway 4
Ravenna 4
Somerville 4
Southwark 4
Taipei 4
Thessaloníki 4
Bagnolo San Vito 3
Bangalore 3
Buenos Aires 3
Chicago 3
Colchester 3
Damietta 3
Totale 6.249
Nome #
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 321
A validated cellular biobank for β-thalassemia 296
TREATMENT OF BETA-THALASSEMIA PATIENTS WITH RAPAMYCIN (SIROLIMUS): FROM PRE-CLINICAL RESERCH TO A CLINICAL TRIAL 267
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 243
A validated THALAMOSS cellular biobank for β-thalassemia 215
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 193
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 181
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 157
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 146
Structure and Biological Activity of Furocoumarins 134
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 134
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 127
Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia 124
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 122
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 121
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 121
Effects on erythroid differentiation of platinum(II) complexes of synthetic bile acid derivatives 120
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 115
Differentiation and apoptosis in UVA-irradiated cells treated with furocoumarin derivatives 115
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 113
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 113
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 113
Erythroid differentiation ability of butyric acid analogues: Identification of basal chemical structures of new inducers of foetal haemoglobin 112
Induction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproducts 109
Erythroid Induction of Chronic Myelogenous Leukemia K562 Cells Following Treatment with a Photoproduct Derived from the UV-A Irradiation of 5-Methoxypsoralen 108
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 107
Involvement of miRNA in erythroid differentiation 107
null 107
Preparation and biological evaluation of some 1,2-O-isopropylidene-D-hexofuranose esters 105
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 105
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 105
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients 104
null 103
Recent trends in the gene therapy of β-thalassemia 98
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 98
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 97
Synthesis and cellular pharmacology studies of a series of 2-amino-3-aroyl-4-substituted thiophene derivatives 96
Development and molecular characterization of transgenic mice for beta-thalassemia 93
Induction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproducts. 93
Encapsulation of mithramycin into polymeric micelles by microfluidics: Regulation of the expression of the human γ-globin genes 92
Production and molecular characterization of transgenic mice models for screening therapeutic agents for beta-thalassemia 91
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 91
Gene therapy combined with HbF induction in beta-thalassemia 90
null 87
null 85
Everolimus is a potent inducer of erythroid differentation and gamma-globin gene expression in human erythroid cells 84
Effects of Tobramycin activity on premature termination codons and interleukin 8 gene expression 83
Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from beta-thalassaemia patients 82
Increase of the expression of gamma-globin gene in human erytroid cells treated with psoralens 82
Targeting the miR-221/miR-222 cluster in cancer therapy 81
Transcription factors (TFs) negatively regulating gamma-globin gene transcription: BCL11A is down-regulated during mithramycin induction of erythroid cells from beta-thalassemia patients 80
Cellular biosensors for the identification of fetal hemoglobin inducers 77
Production of s-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous s039 thalassemia patients 77
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 77
New synthetic isoxazole derivatives as potent inducer of fetal hemoglobin (HbF) in beta-thalassemia 76
null 75
Gene therapy and fetal hemoglobin induction 74
Thalassemia mouse model for beta-globin gene IVSI-6 mutation 74
Mithramycin-mediated regulation of raptor gene transcription during erythroid differentiation of K562 cells 73
Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs 72
Mithramycin-mediated induction of K562 cell erythroid differentiation is associated with inhibition of the mTOR-CI patway 70
Generation and molecular characterization of a transgenic mouse line carrying a mutated human °39 thalassemia -globin gene 68
Sirolimus-mediated induction of fetal hemoglobin in beta-thalassemia: impact of the XmnI rs74482144 polymophism 68
Down-regulation of LYAR is associated with induction of fetal hemoglobin in mithramycin-treated erythroid cells 67
Therapeutic molecules for the development of a read-through approach for diseases caused by nonsense mutations 65
Readthrough of the premature stop codon beta039-thalassemia 65
Increase of accumulationof gamma-globin mRNA in human erythroid cells treated with psoralens 63
Production of a cellular model for the screening of inducers of fetal haemoglobin 63
Orphan Drugs and Potential Novel Approaches for Therapies of β-Thalassemia: Current Status and Future Expectations 63
Hemoglobin production in beta-thalassemia erythroid cells following alteration of biomolecular pathways regulating globin gene expression 61
Human bladder carcinoma cell line 5637 encapsulated in alginate microbeads: release of interleukins, chemokines and growth factors. 61
Erythroid differentiation induced by mithramycin in K562 cells is associated with inhibition of the mTOR-C1 pathway 58
Efficient CRISPR-Cas9-based genome editing of β-globin gene on erythroid cells from homozygous β039-thalassemia patients 56
Expression of miR-210 during erythroid differentiation and induction of gamma-globin gene expression 55
Sex-specific transcriptional profiles identified in β-thalassemia patients 53
A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs 52
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin) 52
null 52
Novel biological activity of psoralens. Induction of accumulation of g-globin mRNA in human erythroid cells 52
Induction of accumulation of gamma-globin mRNA in human erythroid cells treated with psoralens 50
Induction of accumulation of gamma-globin mRNA in human erythroid cells treated with psoralens 48
null 48
Evidences for miRNA regulation of BCL11A gene expression 47
null 44
Co-Treatment of Erythroid Cells from β-Thalassemia Patients with CRISPR-Cas9-Based β039-Globin Gene Editing and Induction of Fetal Hemoglobin 40
null 40
Ultra sensitive plasmonic devices for early cancer diagnosis 39
Effects of Sirolimus treatment on patients with β-Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4+ and CD8+ T cells 38
Treatment of erythroid precursor cells from β‐thalassemia patients with cinchona alkaloids: Induction of fetal hemoglobin production 37
Teaching during COVID-19 pandemic in practical laboratory classes of applied biochemistry and pharmacology: A validated fast and simple protocol for detection of SARS-CoV-2 Spike sequences 36
Development of a transgenic mouse line carrying a functional human Beta-globin gene with the IVSI-6 thalassemia mutation for in vivo screening and validation of aberrant splicing correctors 36
Decrease in α-Globin and Increase in the Autophagy-Activating Kinase ULK1 mRNA in Erythroid Precursors from β-Thalassemia Patients Treated with Sirolimus 34
THALAssaemia MOdular Stratification System for personalized therapy of beta-thalassemia 34
null 32
Inhibitory effects of SARS-CoV-2 spike protein and BNT162b2 vaccine on erythropoietin-induced globin gene expression in erythroid precursor cells from patients with β-thalassemia 30
Furocoumarins photolysis products induce differentiation of human erythroid cells 28
The rs368698783 (G>A) Polymorphism Affecting LYAR Binding to the Aγ-Globin Gene Is Associated with High Fetal Hemoglobin (HbF) in β-Thalassemia Erythroid Precursor Cells Treated with HbF Inducers 28
Increased Expression of α-Hemoglobin Stabilizing Protein (AHSP) mRNA in Erythroid Precursor Cells Isolated from β-Thalassemia Patients Treated with Sirolimus (Rapamycin) 25
Effects of Sirolimus Treatment on Fetal Hemoglobin Production and Response to SARS-CoV-2 Vaccination: A Case Report Study 25
Production and Characterization of K562 Cellular Clones Hyper-Expressing the Gene Encoding α-Globin: Preliminary Analysis of Biomarkers Associated with Autophagy 24
Totale 8.948
Categoria #
all - tutte 44.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 443
Totale 44.913


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020437 0 0 0 0 0 0 0 0 119 200 76 42
2020/20211.248 98 64 65 92 89 126 58 135 35 155 213 118
2021/2022852 87 77 37 25 50 42 46 37 23 80 85 263
2022/2023958 95 91 23 125 174 129 72 82 81 8 42 36
2023/2024673 34 103 27 17 82 124 78 45 10 8 16 129
2024/20251.462 74 57 201 141 270 189 73 104 353 0 0 0
Totale 9.103